Letters Orphan drugs

Viridian Pharma replies

BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c7010 (Published 07 December 2010) Cite this as: BMJ 2010;341:c7010
  1. Timothy J Rockley, medical director1
  1. 1Viridian Pharma, Newport, Gwent NP18 2AB, UK
  1. tjrockley{at}viridianpharma.co.uk

In their open letter Nicholl and colleagues say that caffeine treatment for apnoea of prematurity has been subject to “massive” price rises in …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe